Percy Carter

Percy Carter

Chief Tech/Sci/R&D Officer at BLUEPRINT MEDICINES CORPORATION

Net worth: 5 M $ as of 2024-03-30

53 year
Health Technology
Consumer Services
Finance

Profile

Dr. Percy H. Carter is a Chief Scientific Officer at FibroGen, Inc. Dr. Carter was previously employed as a Senior Vice President & Head-Discovery by Bristol Myers Squibb Co. and a Global Head-Discovery Sciences by Janssen Research & Development LLC. He received his undergraduate degree from Dartmouth College, an MBA from Massachusetts Institute of Technology and a doctorate degree from Harvard University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-06 48,331 ( 0.08% ) 5 M $ 2024-03-30

Percy Carter active positions

CompaniesPositionStart
BLUEPRINT MEDICINES CORPORATION Chief Tech/Sci/R&D Officer 2021-05-18
All active positions of Percy Carter

Former positions of Percy Carter

CompaniesPositionEnd
FIBROGEN, INC. Chief Tech/Sci/R&D Officer 2021-07-11
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Percy Carter's experience

Training of Percy Carter

Dartmouth College Undergraduate Degree
Harvard University Doctorate Degree
Massachusetts Institute of Technology Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Percy Carter's experience

Connections

98

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

FIBROGEN, INC.

Health Technology

BLUEPRINT MEDICINES CORPORATION

Health Technology

Private companies1

Commercial Services

See company connections